As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs.
"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
A new report from the Federal Trade Commission is uncovering what appears to be a major driver of the high cost of ...
A new Federal Trade Commission (FTC) report found that the three largest Pharmacy Benefit Managers (PBMs ... Pharmaceutical Care Management Association Vice President of Public Affairs Greg ...
The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback